Efficacy and Safety of Stereotactic Radiotherapy in Cushing's Disease: A Single Center Experience.

Tugce ApaydınHande Mefkure OzkayaSebnem Memis DurmazRasim MeralPinar Kadioglu

Published in: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association (2020)

In this current single center experience, postoperative cortisol and 1mg DST levels were found as the determinants of time to remission. Although medical therapy before RT did not affect the rate of- and time to remission, medical therapy after RT prolonged the time to biochemical control . This latter finding might suggest a radioprotective effect of cortisol lowering medication use on peri-RT period.

Keyphrases

healthcare
disease activity
early stage
patients undergoing
radiation therapy
ulcerative colitis
stem cells
rheumatoid arthritis
systemic lupus erythematosus
radiation induced
cell therapy
brain metastases
smoking cessation
replacement therapy